Gilead Sciences Inc. shares increased -1.47% which is 0.77% higher to $71.71 Monday. This proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, -1.07% rising 0.26% to 4,479.71 and the Dow Jones Industrial Average DJIA, -1.08% rising 0.31% to 35,625.40.
Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $71.39, which the company reached on August 13th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson JNJ, -1.27% rose 0.90% to $177.84, Merck & Co. Inc. MRK, -1.32% rose 1.58% to $77.93, and AbbVie Inc. ABBV, -1.98% rose 1.66% to $118.41.
Investment company Axiom Investment Management LLC buys Gilead Sciences Inc, Alibaba Group Holding, ARK Fintech Innovation ETF, Impinj Inc, Exelixis Inc, sells Beyond Meat Inc, The Lovesac Co, Farfetch, Nucor Corp, Parker Hannifin Corp during the 3-months ended 2021Q2. As of 2021Q2, Axiom Investment Management LLC owns 156 stocks with a total value of $129 million.